MX2019008292A - Composiciones probioticas y usos de las mismas. - Google Patents

Composiciones probioticas y usos de las mismas.

Info

Publication number
MX2019008292A
MX2019008292A MX2019008292A MX2019008292A MX2019008292A MX 2019008292 A MX2019008292 A MX 2019008292A MX 2019008292 A MX2019008292 A MX 2019008292A MX 2019008292 A MX2019008292 A MX 2019008292A MX 2019008292 A MX2019008292 A MX 2019008292A
Authority
MX
Mexico
Prior art keywords
lactobacillus
probiotic compositions
dsm
prevention
treatment
Prior art date
Application number
MX2019008292A
Other languages
English (en)
Spanish (es)
Inventor
Lazou Ahrén Irini
AGARDH Daniel
Niklas Larsson Lars
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1700542.2A external-priority patent/GB201700542D0/en
Priority claimed from GBGB1709731.2A external-priority patent/GB201709731D0/en
Application filed by Probi Ab filed Critical Probi Ab
Publication of MX2019008292A publication Critical patent/MX2019008292A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MX2019008292A 2017-01-12 2018-01-12 Composiciones probioticas y usos de las mismas. MX2019008292A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1700542.2A GB201700542D0 (en) 2017-01-12 2017-01-12 Probiotic compositions and uses thereof
GBGB1709731.2A GB201709731D0 (en) 2017-06-19 2017-06-19 Probiotic compositions and uses thereof
PCT/EP2018/050789 WO2018130667A1 (en) 2017-01-12 2018-01-12 Probiotic compositions and uses thereof

Publications (1)

Publication Number Publication Date
MX2019008292A true MX2019008292A (es) 2019-09-16

Family

ID=61386800

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019008292A MX2019008292A (es) 2017-01-12 2018-01-12 Composiciones probioticas y usos de las mismas.

Country Status (14)

Country Link
US (1) US11166993B2 (https=)
EP (1) EP3568144B1 (https=)
JP (1) JP7089523B2 (https=)
KR (1) KR102500496B1 (https=)
CN (1) CN110177561B (https=)
AU (1) AU2018207946B2 (https=)
BR (1) BR112019014418A2 (https=)
CA (1) CA3049624A1 (https=)
CL (1) CL2019001938A1 (https=)
MX (1) MX2019008292A (https=)
MY (1) MY195253A (https=)
PH (1) PH12019501629A1 (https=)
RU (1) RU2763311C2 (https=)
WO (1) WO2018130667A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112584848A (zh) * 2018-06-18 2021-03-30 普罗比公司 益生菌组合物及其用途
IT201900014550A1 (it) * 2019-08-09 2021-02-09 Abiogen Pharma Spa Uso di colecalciferolo come agente attivo nel trattamento della celiachia
CN116869141A (zh) * 2022-05-05 2023-10-13 内蒙古一康健康发展有限责任公司 一种具有保健功能的益生菌复合物及其制备方法
KR102845919B1 (ko) * 2023-02-28 2025-08-14 주식회사 피엘비앤비 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물
CN119279210A (zh) * 2024-12-16 2025-01-10 山东健源生物科技有限公司 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
ZA200802934B (en) * 2005-10-06 2009-09-30 Probi Ab Use of lactobacillus for treatment of virus infections
AU2006297896B2 (en) 2005-10-06 2011-12-08 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
DK1996696T3 (en) 2006-03-17 2017-03-20 Probi Ab Thermostable lactobacillus strains
WO2007108763A1 (en) 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
CN102438643B (zh) 2008-11-30 2015-07-01 免疫桑特公司 用于治疗乳糜泻的组合物和方法
EP2581461B1 (en) * 2011-10-14 2014-09-24 GenMont Biotech Incorporation Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases
ES3010649T3 (en) 2012-06-18 2025-04-04 Heinz Co Brands H J Llc Gluten-related disorders
US10245290B2 (en) * 2013-04-03 2019-04-02 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis
ES2764210T3 (es) * 2014-11-25 2020-06-02 Dsm Ip Assets Bv Lactobacillus para usar como probiótico

Also Published As

Publication number Publication date
RU2763311C2 (ru) 2021-12-28
US20190358275A1 (en) 2019-11-28
WO2018130667A1 (en) 2018-07-19
EP3568144C0 (en) 2024-05-08
CL2019001938A1 (es) 2019-09-27
CA3049624A1 (en) 2018-07-19
AU2018207946A1 (en) 2019-07-25
AU2018207946B2 (en) 2024-07-18
RU2019121145A3 (https=) 2021-04-26
EP3568144A1 (en) 2019-11-20
RU2019121145A (ru) 2021-02-12
JP7089523B2 (ja) 2022-06-22
US11166993B2 (en) 2021-11-09
JP2020513780A (ja) 2020-05-21
CN110177561B (zh) 2023-09-12
EP3568144B1 (en) 2024-05-08
KR20190104568A (ko) 2019-09-10
BR112019014418A2 (pt) 2020-04-14
MY195253A (en) 2023-01-11
PH12019501629A1 (en) 2020-06-01
CN110177561A (zh) 2019-08-27
KR102500496B1 (ko) 2023-02-16

Similar Documents

Publication Publication Date Title
PH12019501629A1 (en) Probiotic compositions and uses therof
MX2022000369A (es) Cepa bacteriana de bifidobacterium bifidum, las composiciones de la misma y usos relacionados.
EP4086334A4 (en) LACTOBACILLUS FERMENTUM STRAIN AND COMPOSITION THEREOF FOR PREVENTING OR TREATING METABOLIC DISEASES
MY160508A (en) Lactobacillus plantarum strains as hypocholesterolemic agents
EA202091389A1 (ru) Композиция на основе пробиотиков и её применение
NZ712959A (en) Probiotic strains for use in treatment or prevention of osteoporosis
MX346458B (es) Composicion probiotica para la salud bucal.
ZA202105310B (en) Probiotic compositions comprising lactobacillus reuteri strains and methods of use
PH12018550110B1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
NZ777234A (en) Compositions comprising bacterial strains
EP4293033A3 (en) Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides
EP4086335A4 (en) LACTOBACILLUS FERMENTUM STRAIN, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES, INCLUDING THE SAME
MY161495A (en) Virus like particle compositions and methods of use
BR112017023636A2 (pt) suplemento dietético
SA519400920B1 (ar) استخدام المعززات الحيوية في علاج و/أو الوقاية من التهاب الجلد التأتبي
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
WO2020091180A3 (ko) 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
WO2020091179A3 (ko) 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
PH12021553242A1 (en) Novel probiotic composition for regulation of intestinal immunity
WO2018135843A3 (ko) 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 락토바실러스 퍼멘텀 균주 및 이를 포함하는 조성물
MX2024008818A (es) Un producto de combinacion util para profilaxis y tratamiento de sindrome de intestino irritable.
HUE072158T2 (hu) Lactobacillus salivarus törzs és alkalmazása malacok elválasztás utáni hasmenésének megelõzésében és kezelésében
MX2020013860A (es) Composiciones probioticas y sus usos.
TW201613549A (en) Abraisive oral care composition
EP4375365A4 (en) NOVEL STRAIN OR COMPOSITION OF LACTOBACILLUS PARACASEI ATG-E1 COMPRISING SAME FOR PREVENTING OR TREATING RESPIRATORY DISEASE